Stig Östlund

torsdag, juni 22, 2017

Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older — NEJM

Click -->Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older — NEJM: Original Article from The New England Journal of Medicine —

Bloggarkiv